Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 May 23, 2024
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
4 May 20, 2024 OWNERSHIP DOCUMENT
S-8 May 16, 2024 FORM S-8
POS AM May 16, 2024 POS AM
10-K May 16, 2024 10-K
POSASR May 16, 2024 POSASR
8-K May 16, 2024 FORM 8-K
SC 13G/A Apr 10, 2024
SC 13G/A Apr 10, 2024
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
← Newer Page 9 of 27 · 669 filings Older →